Blue Cross Mounjaro Prior Authorization: Requirements, Forms, and Denial Fixes
What Blue Cross actually needs to approve Mounjaro — the type 2 diabetes proof, the PA packet, the denial translator, and what to do today.
Your pharmacy rang it up, and instead of a price you got two words: prior authorization. Or maybe a letter showed up that just says “denied.” Either way you’re stuck, the clock is ticking, and you’re staring at a price that can top $1,000 a month if your plan doesn’t pay. Take a breath. This is more fixable than most people think.
Blue Cross Mounjaro prior authorization has the strongest coverage path when Mounjaro is prescribed for type 2 diabetes and your doctor sends the right proof — a diabetes diagnosis, lab evidence, past medication history, the dose and quantity, and confirmation you’re not taking another GLP-1 at the same time. The catch most people miss: “Blue Cross” is not one plan. It’s dozens of separate, locally-run companies — each with its own criteria.
Mounjaro + Blue Cross: find your situation
| Your situation | What Blue Cross is likely asking for | What to do next |
|---|---|---|
| You have type 2 diabetes | Diabetes diagnosis (ICD-10 or lab), medication history, dose/quantity, no overlapping GLP-1 | Build a complete PA packet before your doctor submits |
| You want it only for weight loss | Most plans deny Mounjaro here -- it's the diabetes-labeled tirzepatide | Ask about Zepbound or your plan's weight-loss drug benefit |
| Your PA was denied | Depends on the reason: missing info, no diabetes proof, step therapy, dose limit, or flat exclusion | Read the denial letter, then use the denial translator below |
| Your doctor won't handle the PA | Someone has to submit and follow up on the paperwork | Compare a provider-assisted route (LillyDirect or Sesame) |
Does Blue Cross require prior authorization for Mounjaro?
Nearly all the Blue Cross plans we checked require prior authorization for Mounjaro, but there is no single national Blue Cross rule. Prior authorization simply means your doctor has to send proof before the plan agrees to pay.
“Blue Cross” is not one company
This is the single most useful thing to understand. There isn’t one Blue Cross rulebook.
- Each local Blue plan (FEP Blue, Blue Cross of Massachusetts, Blue Cross NC, Florida Blue, BCBS Michigan, and so on) sets its own medical policy.
- Your employer can change the benefit — some plans cover GLP-1 drugs; some carve them out entirely.
- A pharmacy benefit manager — the company that runs your drug coverage behind the scenes (often CVS Caremark, CarelonRx, Prime Therapeutics, or Express Scripts) — actually processes the request.
Prior authorization, step therapy, and quantity limits — in plain words
| Term | What it means |
|---|---|
| Prior authorization (PA) / prior approval | The plan wants proof before it pays |
| Step therapy | The plan wants you to try a cheaper, preferred drug first (like metformin), unless you can show it failed, caused side effects, or isn't safe for you |
| Quantity limit | The plan caps how much it will cover per fill -- a high dose or large supply can trip a rejection |
| Formulary exception | A request to cover a drug that isn't normally on your plan's covered list |
What happens when the pharmacy says “PA required”
- The pharmacy runs your claim.
- The claim rejects with a "prior authorization required" message.
- Your prescriber submits the PA to the plan or its pharmacy benefit manager.
- The plan reviews it against its criteria.
- You get an approval, a denial, or a request for more information.
- If it's denied, your next move depends on why -- which we cover below.
Does Blue Cross cover Mounjaro for type 2 diabetes?
Blue Cross plans are far more likely to cover Mounjaro when it’s for type 2 diabetes and the request proves the plan’s medical-necessity rules. Verified Blue plan policies (FEP Blue, Blue Cross of Massachusetts, Blue Cross NC, Florida Blue) all tie coverage to a documented diabetes diagnosis. The diabetes path is the strong path.
The type 2 diabetes proof Blue Cross may ask for
- An ICD-10 diagnosis code for type 2 diabetes (your doctor picks the correct one)
- A lab value confirming diabetes — your A1c, fasting plasma glucose, an oral glucose tolerance test (OGTT), or a random glucose reading with symptoms
- Your current or past diabetes medications (for example, metformin or insulin)
- A short note explaining why Mounjaro is the right choice for you
Why “my doctor prescribed it” isn’t enough
A prescription means a clinician decided the drug may be right for you. Coverage is a separate decision made by your insurance. The plan can still ask for diagnosis proof, labs, past medications, dose, and quantity before it pays. A denial often isn’t “this drug is wrong for you” — it’s “you didn’t send us X yet.” Those are very different problems, and the second one is usually fixable.
What does Blue Cross actually need to approve a Mounjaro prior authorization?
The common approval packet is: diabetes diagnosis proof, lab evidence or an ICD-10 code, your prior or current diabetes medication history, the requested dose and quantity, and confirmation you’re not combining Mounjaro with another GLP-1 drug. Give them a complete packet the first time and you skip the back-and-forth.
The Mounjaro PA packet
| What to include | Why it matters | Examples to ask your prescriber about | Backed by |
|---|---|---|---|
| Type 2 diabetes diagnosis | Most criteria require Mounjaro to treat diabetes | ICD-10 code, chart diagnosis, diagnosis date | FEP Blue; Blue Cross MA; Blue Cross NC |
| Lab evidence | Many plans want objective proof | A1c, fasting glucose, OGTT, random glucose with symptoms | Blue Cross MA policy #056 |
| Medication history | Some plans require prior diabetes drug use | metformin, glipizide, insulin, SGLT2, DPP-4 | Blue Cross NC; Florida Blue |
| Dose and quantity | Plans cap units and fills | Requested strength, weekly dosing, pens per fill | FEP Blue (quantity limits) |
| No duplicate GLP-1 | Most criteria bar combining GLP-1/GIP drugs | Not also on Ozempic, Wegovy, Zepbound, Trulicity | FEP Blue; Blue Cross MA; BCBSM/BCN |
| Renewal proof (later) | Renewals often need proof it's working | A1c improvement or stability, no serious side effects | BCBSM/BCN (one-year approval) |
What to hand your doctor before they submit
Copy this, fill it in, and send it to your prescriber’s office:
- Your Blue Cross member ID
- Your pharmacy benefit card (if it's separate)
- Your pharmacy benefit manager's name (Caremark, CarelonRx, Prime, Express Scripts, etc.)
- Medication: Mounjaro, with the dose and how often
- Your diagnosis and the date
- Recent labs with dates (A1c, glucose)
- Diabetes medications you've taken, with rough dates and what happened
- Any side effects or reasons a past drug didn't work
- The pharmacy rejection message
- Your denial letter, if you already got one
- Don’t ask your doctor to use a diagnosis code you don’t actually have.
- Don’t present Mounjaro as a weight-loss drug.
- Don’t hide that the goal is weight loss only.
- Don’t stack Mounjaro with another GLP-1 unless your prescriber and plan clearly allow it.
A stronger PA isn’t a more creative one. It’s a more complete and accurate one.
Blue Cross Mounjaro prior authorization requirements, by plan
Verified policies all point to the same core task: prove type 2 diabetes and send the plan-specific evidence. Use this matrix as a map of what Blue plans commonly ask — then confirm your own plan.
Last verified: . Editorial comparison of public criteria. Not a guarantee of coverage or approval.
| Source / plan | What the official source shows | What it means for you |
|---|---|---|
| FDA Mounjaro label | Approved to improve blood sugar control in adults and kids 10+ with type 2 diabetes | Your case is strongest for diabetes -- Mounjaro is not the clean weight-loss coverage path |
| FEP Blue / CVS Caremark | Lists Mounjaro among GLP-1 diabetes drugs that may be covered with documented type 2 diabetes; applies quantity limits and a 12-month approval; approves only when the use is covered and prescribed appropriately | The clearest federal-plan example of what Mounjaro prior approval looks like |
| Blue Cross of Massachusetts (policy #056) | Approves only when all criteria are met: type 2 diabetes confirmed by ICD-10 or a qualifying lab, no concurrent GLP-1/GIP drug, prior diabetes-medication documentation; 12-month approval | Same pattern: diabetes proof + no overlap + a renewal check |
| Blue Cross of Massachusetts (2026 update) | Coverage for GLP-1s ends January 1, 2026 except for type 2 diabetes (as plans renew); Mounjaro still covered for diabetes with PA; weight-loss exclusion can't be appealed | A "no" can mean an excluded benefit, not just missing paperwork |
| BCBS Michigan / BCN | Requires treatment of type 2 diabetes or a trial of a generic/preferred diabetes medication; no combination with another GLP-1; one-year initial approval; renewal needs documented benefit and no serious side effects | Some plans want a prior-medication step, not just the diagnosis |
| Blue Cross NC (Medicare Part D) | Mounjaro approved only when not for weight loss alone, with a type 2 diabetes diagnosis, plus current use within 180 days or a metformin/oral-med pathway (trial, ineffective response, intolerance, or contraindication); no concurrent GLP-1 | "Weight loss alone" is the red line; prior oral-med history can be required |
| Florida Blue (commercial, 2025 update) | Requires PA for GLP-1s; covers them for type 2 diabetes (Mounjaro is on the preferred list); commonly requires a tried/failed oral diabetes drug like metformin; excludes weight-loss use without a rider | Verify your specific plan and formulary -- not a universal Blue rule |
| Eli Lilly (list price and savings) | List price is $1,112.16 per fill; the savings card can bring eligible commercially insured patients to as little as $25/fill | Coverage status changes your price dramatically -- confirm your tier |
Documentation burden by plan (editorial read)
How many separate documents each plan’s criteria appear to ask for — not an approval-odds score.
| Plan / source | Documentation burden |
|---|---|
| FEP Blue / CVS Caremark | Medium-High |
| Blue Cross of Massachusetts | High |
| BCBS Michigan / BCN | High |
| Blue Cross NC | High |
| Florida Blue | Plan-specific (verify) |
Where do you find the Blue Cross Mounjaro prior authorization form?
Use your exact Blue Cross plan or pharmacy benefit manager’s form — not a random Blue Cross PDF you found online. The wrong plan’s form is one of the easiest ways to lose a week.
- FEP Blue members: prior approval runs through CVS Caremark — your prescriber can submit electronically, by fax, or by mail. Electronic submissions tend to be the fastest.
- Find your PBM first. The form and portal depend on whether your drug benefit is run by CVS Caremark, CarelonRx, Prime Therapeutics, or Express Scripts.
- Let your prescriber’s office pull the form. Most clinics submit prior authorizations through an electronic PA system that auto-loads the right plan’s questions.
What diagnosis codes and lab results should your doctor include?
Eli Lilly’s prior-authorization materials list example type 2 diabetes ICD-10 codes such as E11.65, E11.8, and E11.9, and Blue plans may also ask for an A1c, fasting glucose, or other diabetes-confirming results. Your prescriber chooses the correct code and evidence based on your real medical record.
Example ICD-10 codes (your prescriber decides)
Examples from Lilly’s PA guide, not coding advice.
| Code | What it describes | Note |
|---|---|---|
| E11.65 | Type 2 diabetes with high blood sugar (hyperglycemia) | Example only; prescriber chooses |
| E11.8 | Type 2 diabetes with unspecified complications | Example only; prescriber chooses |
| E11.9 | Type 2 diabetes without complications | Example only; prescriber chooses |
Can Blue Cross approve Mounjaro for weight loss only?
Mounjaro vs. Zepbound, in insurance language
| Drug | Active ingredient | FDA label | Insurance coverage path |
|---|---|---|---|
| Mounjaro | Tirzepatide | Type 2 diabetes | Diabetes coverage path |
| Zepbound | Tirzepatide | Obesity/weight management; moderate-to-severe obstructive sleep apnea in adults with obesity | Weight-management path and sleep-apnea path |
If your goal is weight loss
| Your situation | Better question to ask your plan |
|---|---|
| No type 2 diabetes diagnosis | "Does my plan cover Zepbound or any anti-obesity medication?" |
| Obesity, or overweight with a related condition | "Does my plan include a weight-loss drug benefit?" |
| Moderate-to-severe sleep apnea with obesity | "Does my plan cover Zepbound for sleep apnea?" |
| Mounjaro denied as "weight loss" | "Was this a PA denial I can fix, or a benefit exclusion?" |
Benefit exclusion vs. PA denial — know the difference
If Mounjaro won’t be covered, find your real path. Our free 60-second matcher points you to a diabetes path, a Zepbound path, an appeal, or a cash-pay option — based on your actual situation.
Ro carries Zepbound for weight loss — not Mounjaro.
How do you submit a Blue Cross Mounjaro prior authorization?
In most cases your prescriber submits the PA, not you. Your job is to make sure their office has the right plan details, your diagnosis and labs, your medication history, and any denial letter — so the first submission is complete.
Step-by-step submission workflow
- Confirm your exact Blue Cross plan name.
- Find your pharmacy benefit manager (often on your card or portal).
- Check whether Mounjaro is on your formulary or needs PA.
- Ask how PA is submitted -- electronic PA, a portal, or fax.
- Send your prescriber the full packet (the checklist above).
- Ask the office when they submitted it.
- Call Blue Cross or your PBM to confirm they received it.
- Track the result and save any denial letter.
A script to call Blue Cross
A script to message your prescriber
How long does Blue Cross Mounjaro prior authorization take?
A clean electronic submission can be decided in hours, while other routes can take a few business days. The fastest way to cut the wait isn’t to ask “how long?” — it’s to make sure the first request includes everything.
| Why some requests move fast | Why some requests stall |
|---|---|
|
|
Why was my Blue Cross Mounjaro prior authorization denied?
A Mounjaro denial is usually a category of problem, not one problem. The fix depends entirely on which one you got — so the denial letter is your most important document.
Denial reason translator
| What the denial says | What it usually means | What to do |
|---|---|---|
| "Criteria not met" | Your packet didn't prove the plan's rule | Ask for the exact criterion and the missing item |
| "No type 2 diabetes diagnosis" | The plan needs diabetes documentation | Submit your diagnosis/lab record (if accurate) |
| "Weight loss not covered" | It was read as a weight-loss request | Ask about Zepbound or an anti-obesity benefit |
| "Step therapy required" | The plan wants proof you tried a preferred drug | Document the trial, failure, side effects, or contraindication |
| "Quantity limit exceeded" | The dose or fill is over the cap | Adjust the quantity or appeal on medical necessity |
| "Concurrent GLP-1 therapy" | The plan sees another GLP-1 on file | Clarify the switch or discontinuation with your prescriber |
| "Benefit exclusion" | The plan doesn't cover that use at all | Appeal odds are low -- check alternatives instead |
How do you appeal a Blue Cross Mounjaro denial?
Appeal the exact denial reason — not the unfairness of it. HealthCare.gov confirms you generally have the right to appeal a coverage denial, and internal-appeal windows commonly run 180 days, but your denial letter controls the real process and deadline.
Your appeal packet
- The denial letter
- The plan criterion you're addressing
- A letter from your prescriber
- Your diagnosis documentation
- Your lab results
- Your medication history
- Notes on any side effects, intolerance, or contraindication
- Pharmacy records
- The corrected dose or quantity, if that was the issue
- A short statement that answers each denial reason
| Situation | Best move |
|---|---|
| Information was simply missing | Resubmission may be faster than a formal appeal |
| The plan applied its criteria wrong | Formal appeal is the right tool |
| Benefit exclusion (applied correctly) | Appeals are tough -- focus on alternatives |
“I am appealing the denial of my Mounjaro prior authorization dated [date]. The denial reason states [reason]. The attached documentation addresses that criterion directly: [diagnosis], [labs], [medication history], [clinical rationale], [dose/quantity], and confirmation of [no concurrent GLP-1 use]. Please review under my plan’s current Mounjaro prior authorization criteria.”
What if you have type 1 diabetes, prediabetes, PCOS, or obesity without type 2 diabetes?
These conditions can be medically real and serious, but they may not satisfy a Blue Cross Mounjaro rule that requires type 2 diabetes. Don’t force a Mounjaro PA into the wrong diagnosis — ask your clinician which FDA-approved or plan-covered route actually fits your condition.
| Condition | Coverage reality for Mounjaro | Better path |
|---|---|---|
| Type 1 diabetes | PA criteria are written around type 2 -- the diabetes type can decide the outcome | Talk with your clinician about the appropriate, covered option for type 1 |
| Prediabetes / insulin resistance | Often isn't enough to meet a type 2 diabetes rule alone | Ask about weight-loss coverage or cardiovascular-risk indications |
| PCOS | Mounjaro for PCOS can be off-label, which weakens the insurance case | Ask about Zepbound or your plan's obesity/weight-loss benefit |
| Obesity without type 2 diabetes | Not the diabetes coverage path | Ask about Zepbound -- see the Blue Cross Zepbound guide |
See also: Blue Cross Zepbound coverage guide →
What if Blue Cross wants you to try metformin or another drug first?
Some Blue Cross criteria ask for prior or current diabetes medication history before approving Mounjaro (step therapy), while others lean more on diagnosis and lab proof. If step therapy applies, the useful evidence is specific: the drug you tried, the dates, the dose, and the outcome — failure, side effects, intolerance, or a contraindication. Vague doesn’t move the needle; specific does.
- Pharmacy fill history
- Chart notes
- A clinician statement
- Documented side effects
- A contraindication
- An inadequate response
- A prior paid claim under another insurer
Blue Cross NC’s verified criteria will accept a documented trial of a non-GLP-1 oral diabetes drug like metformin within the past 90 days — or an ineffective response, intolerance, or contraindication. Blue Cross of Massachusetts notes it may use pharmacy claims records to confirm prior metformin use.
How much will Mounjaro cost with Blue Cross — approved or denied?
If Blue Cross approves Mounjaro, your cost depends on your formulary tier, deductible, copay or coinsurance, pharmacy network, and savings-card eligibility. If it’s denied, the list price is $1,112.16 per fill. The key point: coverage status — not the drug — drives your price.
| Outcome | What it means | What to check |
|---|---|---|
| PA approved | Plan covers Mounjaro under your pharmacy benefit | Copay, deductible, tier, quantity limit |
| PA denied but fixable | Coverage may still happen if info was missing | Denial reason, appeal deadline, prescriber letter |
| Benefit excluded | Plan doesn't cover that use | Zepbound benefit, alternatives, cash-pay |
| Commercial insurance + savings card | Can drop cost significantly if eligible | Current Lilly savings-card rules |
| Government insurance (Medicare/Medicaid/VA) | Savings-card rules differ and are often restricted | Medicare/Medicaid/Part D rules |
List price: $1,112.16 per fill (28-day supply, up to four single-dose pens). What you pay depends on coverage, pharmacy, and assistance programs.
Lilly Mounjaro Savings Card: For commercial plans that cover Mounjaro, eligible patients can pay as little as $25/fill (capped at $150/$300/$450 per 1/2/3-month fill, up to $1,950/year). If your commercial plan doesn’t cover Mounjaro, eligible patients may pay as low as $499 for a 1-month fill. Requires commercial drug insurance, age 18+, U.S. or Puerto Rico residency, and a prescription for an approved (diabetes) use. People with Medicare, Medicaid, TRICARE, VA, or other government coverage cannot use it. Program runs through December 31, 2026; terms can change.
Medicare Part D: covers Mounjaro for type 2 diabetes subject to your plan’s formulary and PA rules. For 2026, out-of-pocket cost for covered Part D drugs is capped at $2,100.
The Medicare GLP-1 Bridge — and why it likely won’t change your Mounjaro answer: Starting July 1, 2026, CMS is running a demonstration that gives eligible Part D members access to certain weight-loss GLP-1s — Wegovy, the Zepbound KwikPen, and Foundayo — for a $50 monthly copay. Mounjaro is not part of it. People who qualify for Part D coverage because of type 2 diabetes are not eligible for the Bridge — they keep using regular Part D.
See full breakdown: Mounjaro cost without insurance →
Should you use a telehealth provider to help with Mounjaro prior authorization?
A provider can help only if they can prescribe the right FDA-approved medication and assist with the PA paperwork — and none of them can guarantee Blue Cross will approve Mounjaro. Often, your existing doctor is the best route.
| Route | Mounjaro-specific? | PA / coverage help? | Best for |
|---|---|---|---|
| Your current doctor | Yes, if they prescribed it | Depends on the office | Existing type 2 diabetes care + labs |
| LillyDirect | Yes | Yes -- checks coverage, supports PA when required | Authentic Mounjaro access and PA support |
| Sesame Care | Yes, if a provider confirms | A provider can assist with PA paperwork (if insured) | New provider-assisted Mounjaro path |
| Ro | No Mounjaro route | Zepbound / weight-loss path only | Weight-loss tirzepatide -- NOT Mounjaro PA |
What should you do today if the pharmacy says “PA required”?
Don’t start by appealing. Start by confirming your plan’s rule, then give your prescriber a complete packet so the first submission isn’t missing anything.
Same-day action checklist
- Screenshot the pharmacy rejection.
- Log in to your Blue Cross member portal.
- Find your pharmacy benefit / PBM.
- Search your formulary for Mounjaro.
- Check whether PA, step therapy, or a quantity limit applies.
- Download or request the PA criteria/form.
- Gather your diagnosis, labs, and medication history.
- Message your prescriber with the packet.
- Confirm when the PA was submitted.
- Track the decision and save the denial letter if you get one.
How we built this guide
Built by comparing official FDA labeling, Eli Lilly’s PA and pricing pages, verified Blue plan policies, public PA criteria, and federal appeal and Medicare rules. Last verified: .
| What we verified | Status |
|---|---|
| Mounjaro's FDA indication (type 2 diabetes) and safety boundary | Verified |
| FEP Blue / CVS Caremark GLP-1 prior-approval criteria and electronic-PA process | Verified |
| Blue Cross MA pharmacy policy #056 and 2026 GLP-1 coverage change | Verified |
| Blue Cross NC 2026 Medicare GLP-1 criteria; Florida Blue 2025 commercial GLP-1 PA bulletin | Verified |
| BCBS Michigan / BCN prior-authorization and step-therapy criteria | Verified |
| HealthCare.gov appeal rights and 180-day internal-appeal window | Verified |
| Eli Lilly list price ($1,112.16/fill) and savings-card terms; LillyDirect coverage support | Verified |
| CMS: Medicare GLP-1 Bridge (weight-loss drugs only, $50/month, starting July 1, 2026) | Verified |
| Your own plan's live criteria (rules change) | Verify yourself using call script |
| Current Lilly savings-card terms (expire Dec 31, 2026) | Re-confirm before relying |
Frequently asked questions about Blue Cross Mounjaro prior authorization
- Does Blue Cross cover Mounjaro?
- Sometimes. Blue Cross plans are most likely to cover Mounjaro when it is prescribed for type 2 diabetes and the prior authorization proves the plan's criteria. Coverage for weight loss alone is much weaker, because Mounjaro is the diabetes-labeled tirzepatide brand, not the weight-loss one.
- Does Blue Cross cover Mounjaro for weight loss?
- Most plans do not cover Mounjaro for weight loss alone. If the goal is weight loss and you do not have type 2 diabetes, the better question is whether your plan covers Zepbound or anti-obesity medication.
- What is needed for Mounjaro prior authorization?
- Common documentation includes a type 2 diabetes diagnosis, an ICD-10 code, an A1c or other diabetes lab evidence, prior or current diabetes medication history, the dose and quantity, and confirmation that you are not using another GLP-1 at the same time.
- What ICD-10 code is used for Mounjaro?
- Eli Lilly's prior-authorization materials list example type 2 diabetes codes including E11.65, E11.8, and E11.9, but the correct code must come from your prescriber based on your actual medical record.
- Can my doctor resubmit a denied Mounjaro prior authorization?
- Yes, if the denial was due to missing or incomplete documentation. If it was a benefit exclusion, resubmission will not fix it unless the exclusion was applied to you incorrectly.
- How do I appeal a Mounjaro denial from Blue Cross?
- Read the denial letter, identify the exact reason, gather the missing evidence, ask your prescriber for a medical-necessity letter if appropriate, and submit by the deadline in your letter. HealthCare.gov confirms internal appeals and external review may apply.
- Is FEP Blue's Mounjaro form the same as every Blue Cross plan?
- No. FEP Blue is one plan example, not a universal Blue Cross rule. It shows the kind of information a Blue plan asks for, but you must verify your own plan's criteria.
- Can I use a Mounjaro savings card if Blue Cross denies coverage?
- Possibly, depending on your insurance type. Commercially insured patients may still use the card, often around $499 for a 1-month fill if the plan does not cover the drug, while government insurance programs are excluded. Always verify the current Lilly terms.
- Is Zepbound the same as Mounjaro for Blue Cross coverage?
- No. Both contain tirzepatide, but they have different labeled uses and different insurance paths. Mounjaro is the diabetes path; Zepbound is the weight-management and sleep-apnea path when covered.
Still not sure which GLP-1 program is right for you?
Take our free 60-second matching quiz and get a personalized action plan for your plan, your diagnosis, and your goal.
Get my personalized GLP-1 plan →Weight-loss goal? Check Zepbound coverage on Ro → (sponsored affiliate link, opens in a new tab)Ro carries Zepbound for weight loss — not Mounjaro. $39 first month, then as low as $74/month.
Related guides
- → Blue Cross Zepbound prior authorization
- → Blue Cross Wegovy prior authorization
- → Blue Cross Foundayo prior authorization
- → Does Blue Cross cover Zepbound?
- → GLP-1 telehealth providers that accept Blue Cross
- → Best GLP-1 providers that help with prior authorization
- → Mounjaro cost without insurance
- → Free GLP-1 insurance coverage checker
- → GLP-1 formulary tier explained: 2026 cost decoder
- → Free 60-second GLP-1 matching quiz
Sources
- U.S. Food & Drug Administration -- Mounjaro (tirzepatide) prescribing information and boxed warning
- FEP Blue / CVS Caremark -- Antidiabetic GLP-1 / GIP-GLP-1 prior-approval criteria and FEP prior-approval (electronic PA) information
- Blue Cross Blue Shield of Massachusetts -- Pharmacy Medical Policy #056 (GLP-1 Receptor Agonists for Type 2 Diabetes) and the 2026 GLP-1 coverage update
- Blue Cross NC -- GLP-1 Agonists (Bydureon, Mounjaro, Rybelsus) Prior Authorization Criteria, Medicare Part D (version 04/01/2025)
- Florida Blue -- GLP-1 Prior Authorization Requirement for Commercial Plans (2025 provider bulletin)
- Blue Cross Blue Shield of Michigan / Blue Care Network -- prior authorization and step-therapy coverage criteria
- Blue Cross Blue Shield Association -- overview of independent, locally operated Blue companies
- HealthCare.gov -- How to appeal an insurance company decision (internal appeals and external review)
- Eli Lilly -- Mounjaro list price and Mounjaro Savings Card terms (mounjaro.lilly.com); LillyDirect Mounjaro
- Centers for Medicare & Medicaid Services -- Medicare Part D 2026 out-of-pocket cap; Medicare GLP-1 Bridge
- Sesame Care -- Mounjaro prior-authorization support